Complete Revascularization Showed A Better Cardiac Function Improvement In Patients With Low Ejection Fraction

Authors

  • Tri Wisesa Soetisna, MD, PhD, MHA Department of Cardiothoracic and Vascular Surgery, National Cardiovascular Centre Harapan Kita, Jakarta, Indonesia https://orcid.org/0000-0002-7428-3600
  • Wiraga Adi Nugraha, MD Department of Cardiothoracic and Vascular Surgery, National Cardiovascular Centre Harapan Kita, Jakarta, Indonesia https://orcid.org/0000-0002-2295-4628
  • Fitri Setyani Rokim, MD Department of Cardiothoracic and Vascular Surgery, National Cardiovascular Centre Harapan Kita, Jakarta, Indonesia
  • Lisca Namretta, MD Department of Cardiothoracic and Vascular Surgery, National Cardiovascular Centre Harapan Kita, Jakarta, Indonesia
  • Muhammad Bagus Ronidipta Pradana, MD Department of Cardiothoracic and Vascular Surgery, National Cardiovascular Centre Harapan Kita, Jakarta, Indonesia
  • Digjaya Utama, MD, PhD Department of Cardiothoracic and Vascular Surgery, National Cardiovascular Centre Harapan Kita, Jakarta, Indonesia

DOI:

https://doi.org/10.1532/hsf.4123

Keywords:

Coronary artery bypass grafting, revascularization, cardiac function, ejection fraction, systolic dysfunction

Abstract

Purpose: This study aimed to compare postoperative ejection fraction (EF) in response to coronary artery bypass grafting (CABG) among patients with preoperative EF <35% and >35%.

Methods: A retrospective study was conducted in a single institution using clinical data of 660 patients undergoing elective on-pump CABG in 2018-2019. Patients were classified into two groups based on preoperative left ventricle ejection fraction (<35% and >35%). The primary endpoint was the change of postoperative ejection fraction.

Results: In this study, 72 patients had preoperative left ventricle ejection fraction <35% (group A) while the other 588 patients had ejection fraction >35% (group B). Among both groups, the duration of cardiopulmonary bypass (CPB) and aortic clamp (AxC) were not significantly different (P > 0.05). The transformation of pre- and postoperative EF in groups A and B was significantly different (2.91+10.31 vs. -0.14+4.57, P < 0.001). There was a significant difference in the duration of ICU stay (73.42+112.55 vs. 34.43+64.99, P < 0.001) and postoperative ventilatory support (25.54+43.92 vs. 16.42+45.87, P < 0.008) between group A and B.

Conclusion: Low preoperative EF showed better improvement in cardiac function after surgery. We concluded that the result could be affected by revascularization of hibernating myocardium. 

References

Adabag AS, Rector T Fau - Mithani S, Mithani S Fau - Harmala J, et al. Prognostic significance of elevated cardiac troponin I after heart surgery. (1552-6259 (Electronic).

Afridi I, Grayburn PA, Panza JA, Oh JK, Zoghbi WA, Marwick TH. 1998. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol. Oct;32(4):921-6.

Anavekar NS, Chareonthaitawee P, Narula J, Gersh BJ. 2016. Revascularization in Patients With Severe Left Ventricular Dysfunction: Is the Assessment of Viability Still Viable? Journal of the American College of Cardiology. 67(24):2874-2887.

Bauersachs R, Zeymer U, Brière J-B, Marre C, Bowrin K, Huelsebeck M. 2019. Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review. Cardiovascular Therapeutics. 8295054.

Hillis LD, Smith PK, Anderson JL, et al. 2011. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. Circulation. 124(23):e652-e735.

Khaled S, Kasem E, Fadel A, et al. 2019. Left ventricular function outcome after coronary artery bypass grafting, King Abdullah Medical City (KAMC)- single-center experience. The Egyptian Heart Journal. 71(1):2.

Khan MA, Hashim MJ, Mustafa H, et al. 2020. Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study. Cureus. 12(7):e9349.

Kloner RA. 2020. Stunned and Hibernating Myocardium: Where Are We Nearly 4 Decades Later? J Am Heart Assoc. 9(3):e015502.

Koene RJ, Kealhofer JV, Adabag S, Vakil K, Florea VG. 2017. Effect of coronary artery bypass graft surgery on left ventricular systolic function. Journal of Thoracic Disease. 9(2):262-270.

Lakshman HVVSS, Rao V D. 2020. Revascularization in Ischemic Heart Failure: A Review. Indian Journal of Clinical Cardiology. 1(1):31-36.

Leung JM. 1993. Clinical evidence of myocardial stunning in patients undergoing CABG surgery. Journal of cardiac surgery. Mar; 8(2 Suppl):220-3.

Mayala HA, Mafuru M, Mkangala A, et al. 2020. Factors influencing left ventricular ejection fraction in patients with coronary microvascular disease and obstructive coronary artery disease. BMC Research Notes. 13(1):157.

Mehta SR, Wood DA, Storey RF, et al. 2019. Complete Revascularization with Multivessel PCI for Myocardial Infarction. New England Journal of Medicine. 381(15):1411-1421.

Ong ATL, Serruys PW. 2006. Complete Revascularization. Circulation. 114(3):249-255.

Ribeiro G, Nunes A, Antoniali F, Lopes M, Costa C. 2005. The beneficial effect of revascularization on patients with severe left ventricular dysfunction and viable myocardium: reverse remodeling and prognosis. Brazilian Journal of Cardiovascular Surgery. 20.

Roth GA, Mensah GA, Johnson CO, et al. 2020. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study. Journal of the American College of Cardiology. 76(25):2982-3021.

Ryan MJ, Perera D. 2018. Identifying and Managing Hibernating Myocardium: What’s New and What Remains Unknown? Current Heart Failure Reports. 15(4):214-223.

Sun LY, Tu JV, Bader Eddeen A, Liu PP. 2018. Prevalence and Long-Term Survival After Coronary Artery Bypass Grafting in Women and Men With Heart Failure and Preserved Versus Reduced Ejection Fraction. J Am Heart Assoc. 7(12):e008902.

Tunç M, Şahutoğlu C, Karaca N, Kocabaş S, Aşkar FZ. 2018. Risk Factors for Prolonged Intensive Care Unit Stay After Open Heart Surgery in Adults. Turk J Anaesthesiol Reanim. 46(4):283-291.

Published

2022-05-31

How to Cite

Soetisna, T. W., Nugraha, W. A., Rokim, F. S., Namretta, L., Pradana, M. B. R., & Utama, D. (2022). Complete Revascularization Showed A Better Cardiac Function Improvement In Patients With Low Ejection Fraction. The Heart Surgery Forum, 25(3), E425-E428. https://doi.org/10.1532/hsf.4123

Issue

Vol. 25 No. 3 (2022)

Section

Articles

Author Disclosure & Copyright Transfer Agreement

In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.

A current form follows:

The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.

However, Publisher grants back to the author(s) the following:

  1. The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
  2. The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
  3. The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
  4. The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
  5. The right to make oral presentations of material from this work.

Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.

I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.

I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).

I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.

Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).